ASX:AYAHealthcare Services
Is Artrya's (ASX:AYA) US Salix Push Redefining Its AI Cardiac Imaging Investment Narrative?
Artrya has recently attracted increased investor attention for its Salix platform, which uses artificial intelligence to analyse cardiac CT scans and help detect coronary artery disease, supported by ongoing work on clinical validation, regulatory clearances and US market entry.
An interesting aspect of this development is how the push to convert early clinical evidence and regulatory progress into meaningful healthcare provider adoption will test Artrya’s commercialisation model for...